Consolidated Statements of Cash Flows (USD $) In Thousands	12 Months Ended
	Sep. 30, 2011	Sep. 30, 2010	Sep. 30, 2009
Cash flows from operating activities:
Net loss	$ (204,859)	$ (34,049)	$ (189,383)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Depreciation and amortization	10,708	13,405	18,884
Stock-based compensation expense	7,170	11,369	11,839
Inventory impairments and option contract abandonments	35,365	51,839	107,127
Impairment of future land purchase rights	5,569
Goodwill impairment			16,143
Deferred income tax provision (benefit)	5,019	(259)	12,696
Provision for doubtful accounts	305	(3,978)	(1,370)
Excess tax benefit from equity-based compensation	523	3,099	2,273
Equity in (income) loss of unconsolidated joint ventures	(42)	24,350	14,275
Cash distributions of income from unconsolidated joint ventures	450	208	2,991
Loss (gain) on extinguishment of debt	2,343	(44,602)	(148,077)
Changes in operating assets and liabilities:
Decrease (increase) in accounts receivable	4,039	(264)	19,520
Decrease in income tax receivable	2,861	2,238	163,578
(Increase) decrease in inventory	(54,395)	82,504	208,371
Decrease in other assets	5,291	3,835	25,072
Increase (decrease) in trade accounts payable	19,277	(16,867)	(20,086)
Decrease in other liabilities	(17,961)	(22,530)	(150,260)
Other changes	(599)	(613)	232
Net cash (used in) provided by operating activities	(178,936)	69,685	93,825
Cash flows from investing activities:
Capital expenditures	(20,514)	(10,849)	(7,034)
Investments in unconsolidated joint ventures	(1,924)	(5,602)	(25,537)
Increases in restricted cash	(250,839)	(37,439)	(72,168)
Decreases in restricted cash	12,981	47,700	23,004
Distributions from unconsolidated joint ventures			2,054
Net cash used in investing activities	(260,296)	(6,190)	(79,681)
Cash flows from financing activities:
Repayment of debt	(215,376)	(619,806)	(305,399)
Proceeds from issuance of new debt	246,387	374,438	223,750
Proceeds from issuance of cash secured loan	247,368
Debt issuance costs	(5,172)	(9,234)	(7,195)
Common stock issued		166,718
Proceeds from issuance of TEU prepaid stock purchase contracts		57,429
Common stock redeemed	(170)	(159)	(22)
Excess tax benefit from equity-based compensation	(523)	(3,099)	(2,273)
Net cash provided by (used in) financing activities	272,514	(33,713)	(91,139)
(Decrease) increase in cash and cash equivalents	(166,718)	29,782	(76,995)
Cash and cash equivalents at beginning of period	537,121	507,339	584,334
Cash and cash equivalents at end of period	$ 370,403	$ 537,121	$ 507,339